Robert Mills

Robert Mills is currently the Global Regulatory Lead for the Pfizer Oncology Division, leveraging extensive experience in developing and implementing regulatory strategies for biopharmaceuticals and biologics across various global regions. They previously served as the Associate Director of Regulatory Science at Seagen, where they collaborated on global submissions for a range of hematologic malignancies and solid tumors. Robert's earlier roles included significant positions at Genentech and ZymoGenetics, focusing on regulatory CMC for major commercial and investigational products. They are pursuing multiple advanced degrees, including an MS in Pharmaceutical Bioengineering from the University of Washington and a MA in Psychology from Antioch University Seattle.